Sarepta Therapeutics, Inc. (SRPT): Capital Expenditures
$101.97M
Year ended 2025-12-31
$29.16M
Trailing 12 months to 2026-06-30
+49.0%
3-year compound annual growth
+4.4%
5-year compound annual growth
+40.5%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $101.97M | -25.5% | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | $136.96M | +80.0% | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | $76.11M | +146.9% | 2026-03-02, From 2023-01-01 |
| 2022-12-31 | $30.82M | -19.9% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $38.49M | -53.2% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $82.20M | +37.9% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $59.63M | -2.5% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $61.16M | +409.6% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $12.00M | +124.7% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $5.34M | +57.0% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $3.40M | -86.6% | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | $25.44M | +973.6% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $2.37M | n/m | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | $108.0K | -90.8% | 2015-02-26, From 2012-01-01 |
| 2011-12-31 | $1.18M | +41.6% | 2014-03-03, From 2011-01-01 |
| 2010-12-31 | $832.0K | -10.6% | 2013-03-15, From 2010-01-01 |
| 2009-12-31 | $931.0K | n/a | 2012-03-13, From 2009-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $101.97M | -25.5% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $8.86M | +36.3% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $70.06M | +34.9% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $520.50M | +111.2% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $59.09M | +54.3% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $103.04M | +20.6% |
| Alkermes plc. (ALKS) | 2025-12-31 | $40.42M | +20.7% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $58.70M | +71.2% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $66.00M | +127.6% |
Compare SRPT, PTCT, AMRX, UTHR side by side · Screen every company in Pharmaceutical Preparations ↗